|

Zanubrutinib combined with Obinutuzumab Clinical Trials

1 actively recruiting trial

Also known as: Zanubrutinib combined with Obinutuzumab (ZO)

Pipeline

Phase 2: 1

Top Sponsors

  • The First Affiliated Hospital of Xiamen University1

Indications

  • Newly Diagnosed1
  • Follicular Lymphoma1
  • Cancer1

Other1 trial

Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.